Important Update for People Using Protaphane InnoLet Insulin

Novo Nordisk, the company that manufactures Protaphane, is changing some of its insulin products in Australia. This means the Protaphane InnoLet pre-filled pen will no longer be available after February 2025.

What does this important update mean for me?

If you use Protaphane InnoLet, you'll need to switch to a different way of taking your insulin.

Please see the options below:

Protaphane Penfill: This is a cartridge that you use with a reusable insulin pen (called a NovoPen4). This option will only be available until December 2026.
Humulin NPH: This is another type of insulin (similar to protaphane) that comes in a cartridge for use with a reusable pen (called a HumaPen).
Other options: Your doctor might suggest a different type of insulin that's right for you.

Seek advice

Talk to your doctor or diabetes educator as soon as possible. They can help you decide which option is best for you and teach you how to use a new device. It's important to plan to make the switch soon so you don't run out of your current insulin.

Who might be most affected by this important update?

Women with gestational diabetes
People with high blood glucose caused by steroid medications
People who get their nutrition through a feeding tube
Older adults or anyone with trouble using their hands or seeing clearly

Key things to remember:

You'll need a new reusable insulin pen if you switch to cartridges. Your diabetes educator, doctor or pharmacist can help you get the right one and show you how to use it.
Check your blood glucose regularly after changing your insulin to make sure everything is on track.
If you have any questions or concerns about this important update talk to your doctor or diabetes educator.
People currently using Protaphane Innolet for gestational diabetes or temporary high blood glucose due to steroids, might have enough supply to continue. It's important to discuss this with your doctor or diabetes educator. They will assess your individual situation and help you create a plan to switch to a different insulin if necessary.